Analytical Data
-
基因名
BAR1
- Application
-
别名
BAR1；BRCA1-associated RING domain Protein 1
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P12630
-
表达区间
43-395aa
-
氨基酸序列
MYYATTLDIGTPSQSLTVLFDTGSADFWVMDSSNPFCLPNSNTSSYSNATYNGEEVKPSIDCRSMSTYNEHRSSTYQYLENGRFYITYADGTFADGSWGTETVSINGIDIPNIQFGVAKYATTPVSGVLGIGFPRRESVKGYEGAPNEYYPNFPQILKSEKIIDVVAYSLFLNSPDSGTGSIVFGAIDESKFSGDLFTFPMVNEYPTIVDAPATLAMTIQGLGAQNKSSCEHETFTTTKYPVLLDSGTSLLNAPKVIADKMASFVNASYSEEEGIYILDCPVSVGDVEYNFDFGDLQISVPLSSLILSPETEGSYCGFAVQPTNDSMVLGDVFLSSAYVVFDLDNYKISLAQA
-
分子量
44.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BAR1 (Bacteria Artificially Recombinant Protein 1) has emerged as a significant focus in molecular biology and biotechnology due to its potential applications in various fields, including medicine, agriculture, and industrial biotechnology. Researchers have been exploring BAR1 for its role in protein engineering, aiming to develop novel therapeutic proteins with desirable properties such as enhanced stability, efficacy, and specificity. The ability to manipulate BAR1 allows scientists to understand better the underlying mechanisms of protein folding and function, which can lead to the discovery of new drugs or improvements in vaccine development. Furthermore, BAR1’s capacity to express in different host systems facilitates the scaling-up of production for research and commercial purposes. The study of BAR1 also encompasses its interactions with other biomolecules, providing insight into cellular processes and signaling pathways, which are crucial for disease understanding and treatment strategies. Given the growing demand for innovative biopharmaceuticals and sustainable bioprocessing, ongoing research into BAR1 and its derivatives holds promise for addressing critical challenges in health and environmental sectors.
